Suvorexant: A boon for Sleepless Nights

Authors

  • Anjan Khadka Department of Pharmacology, Nepalese Army Institute of Health Sciences, Nepal.
  • Dick Brashier Department of Pharmacology, Armed Forces Medical College, Pune-40, Maharashtra, India.
  • Amol Vijay Khanpure Department of Pharmacology, Armed Forces Medical College, Pune-40, Maharashtra, India.
  • Pem Chuki Department of Pharmacology, Armed Forces Medical College, Pune-40, Maharashtra, India.

DOI:

https://doi.org/10.3126/mjsbh.v14i1.14842

Keywords:

insomnia, orexin, suvorexant, sleep.

Abstract

Insomnia is characterized by difficulty in falling asleep, difficulty maintaining sleep, or experiencing nonrestorative sleep. Insomnia is the most common medical complaint in general practice.  Low efficacy and various side effects limit the use of existing treatment option. Suvorexant is an orexin receptor antagonist (ORA), first in a new class of drugs in development for the treatment of insomnia. It inhibits the wakefulness-promoting orexin neurons of the arousal system thereby promoting the natural transition from wakefulness. It also improves sleep onset and sleep maintenance and has a favorable tolerability and limited side-effect profile.

Downloads

Download data is not yet available.
Abstract
822
PDF
529

Author Biography

Anjan Khadka, Department of Pharmacology, Nepalese Army Institute of Health Sciences, Nepal.

Consultant Orthopedic Surgeon

Downloads

Published

2016-05-09

How to Cite

Khadka, A., Brashier, D., Khanpure, A. V., & Chuki, P. (2016). Suvorexant: A boon for Sleepless Nights. Medical Journal of Shree Birendra Hospital, 14(1), 43–45. https://doi.org/10.3126/mjsbh.v14i1.14842

Issue

Section

Viewpoint